Insulin reduced amyloidogenesis and COX-2-mediated neuroinflammation in astrocytes treated with streptozotocin, which are hallmarks of Alzheimer’s disease [1]. The gene discussed is PTGS2; the disease is early-onset autosomal dominant Alzheimer disease.